Abstract
When deciding to invest in the pharmaceutical industry, several areas represent interesting alternatives. Homeopathy is one of those alternatives. Even if homeopathy is often questioned, several large companies are making profits in this specific industry. This report analyzes the homeopathic market and presents two large actors on the European market: Boiron and Lehning. Finally, this report features a comprehensive financial analysis of both laboratories in order to choose which one to invest in to get the most profitable outcomes.
